-
Seminars in Ultrasound, CT, and MR Feb 2023Transgender patients are seen in breast imaging centers for routine screening mammography and diagnostic imaging of the symptomatic breast. This comprehensive review of... (Review)
Review
Transgender patients are seen in breast imaging centers for routine screening mammography and diagnostic imaging of the symptomatic breast. This comprehensive review of transgender breast imaging aims to update the radiologist on appropriate terminology, breast cancer risk in different patient populations, screening guidelines, and diagnostic scenarios. The chapter concludes with practical tips on how to optimize the patient experience.
Topics: Humans; Female; Breast Neoplasms; Mammography; Transgender Persons; Early Detection of Cancer; Radiologists
PubMed: 36792271
DOI: 10.1053/j.sult.2022.10.002 -
Journal of Breast Imaging Feb 2023US is a widely available, commonly used, and indispensable imaging modality for breast evaluation. It is often the primary imaging modality for the detection and... (Review)
Review
US is a widely available, commonly used, and indispensable imaging modality for breast evaluation. It is often the primary imaging modality for the detection and diagnosis of breast cancer in low-resource settings. In addition, it is frequently employed as a supplemental screening tool via either whole breast handheld US or automated breast US among women with dense breasts. In recent years, a variety of artificial intelligence systems have been developed to assist radiologists with the detection and diagnosis of breast lesions on US. This article reviews the background and evidence supporting the use of artificial intelligence tools for breast US, describes implementation strategies and impact on clinical workflow, and discusses potential emerging roles and future directions.
Topics: Female; Humans; Artificial Intelligence; Ultrasonography, Mammary; Breast; Breast Neoplasms; Mammography
PubMed: 38416959
DOI: 10.1093/jbi/wbac077 -
Salud Publica de Mexico Mar 2021No disponible.
No disponible.
Topics: Breast Neoplasms; Early Detection of Cancer; Female; Humans; Mammography; Quality Improvement
PubMed: 34098614
DOI: 10.21149/12135 -
Journal of Breast Imaging May 2023Early detection of breast cancer through screening mammography saves lives. However, the sensitivity of mammography for breast cancer detection is reduced in women with... (Review)
Review
Early detection of breast cancer through screening mammography saves lives. However, the sensitivity of mammography for breast cancer detection is reduced in women with dense breast tissue. Imaging modalities for supplemental breast cancer screening include MRI, whole breast US, contrast-enhanced mammography, and molecular breast imaging (MBI). Molecular breast imaging with 99mTc-sestamibi is a functional imaging test to identify metabolically active areas in the breast with positioning analogous to mammography. Since 2011, there have been six large, published studies of screening MBI as a supplement to mammography involving over 6000 women from four different institutions. A multicenter, prospective clinical trial of 3000 women comparing breast cancer detection using screening digital breast tomosynthesis alone or in combination with MBI recently completed enrollment. This review focuses on the current evidence of MBI use for supplemental breast cancer screening, the strengths and limitations of MBI, and recent technological advances.
Topics: Female; Humans; Breast Neoplasms; Mammography; Breast Density; Prospective Studies; Early Detection of Cancer; Multicenter Studies as Topic
PubMed: 38416886
DOI: 10.1093/jbi/wbad011 -
Seminars in Roentgenology Apr 2022Artificial intelligence (AI) for breast imaging has rapidly moved from the experimental to implementation phase. As of this writing, Food and Drug Administration... (Review)
Review
Artificial intelligence (AI) for breast imaging has rapidly moved from the experimental to implementation phase. As of this writing, Food and Drug Administration (FDA)-approved mammographic applications are available for triage, lesion detection and classification, and breast density assessment. For sonography and MRI, FDA-approved applications are available for lesion classification. Numerous other interpretive and noninterpretive AI applications are in the development phase. This article reviews AI applications for mammography, sonography, and MRI that are currently available for clinical use. In addition, clinical implementation and the future of AI for breast imaging are discussed.
Topics: Artificial Intelligence; Breast; Breast Neoplasms; Female; Humans; Magnetic Resonance Imaging; Mammography
PubMed: 35523530
DOI: 10.1053/j.ro.2021.12.005 -
Journal of Tissue Viability Nov 2023Skin tears are classed as traumatic wounds mainly caused by shearing and frictional forces. Incidences of skin tears are noted to be significant mostly in the elderly... (Review)
Review
Skin tears are classed as traumatic wounds mainly caused by shearing and frictional forces. Incidences of skin tears are noted to be significant mostly in the elderly population and those with fragile and vulnerable skin. Individuals undergoing mammography are susceptible to skin tears due to factors associated with skin breakdown such as thinning of the epidermis, use of steroids, presence of moisture, but this, when compounded with the procedure of mammography can increase the risk further. Mammography, an x-ray imaging method, which exerts adequate compression force on the breast tissue for the mammographer to obtain a high-quality image for diagnostic purposes. However, when compression force is applied during mammography resulting incidences of cutaneous skin tears can occur. Lack of and under reporting of skin tears during mammography makes it difficult to ascertain the extent of this problem and scale of its incidence. Therefore, the purpose of this narrative review is to focus on providing an overview of skin tears associated with mammography and a discussion of the current literature with regards to its incidence and diagnosis. In addition, the review will also discuss the theoretical and contextual perspective of the prevention and management strategies associated with skin tears.
Topics: Aged; Humans; Lacerations; Skin; Mammography; Soft Tissue Injuries; Pressure
PubMed: 37806846
DOI: 10.1016/j.jtv.2023.09.003 -
The Medical Clinics of North America Nov 2020Among women, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death in the world. The purpose of this article is to review the... (Review)
Review
Among women, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death in the world. The purpose of this article is to review the evidence regarding breast cancer screening for average-risk women. The review primarily focuses on mammographic screening but also reviews clinical breast examinations, emerging screening technologies, and opportunities to build consensus. Wherever possible, the review relies on published systematic reviews, meta-analyses, and guidelines from three major societies (US Preventive Services Task Force, American College of Radiology, and the American Cancer Society) to reflect a range of evidence-based perspectives regarding mammographic screening.
Topics: Breast Neoplasms; Female; Humans; Mammography; Practice Guidelines as Topic; United States
PubMed: 33099447
DOI: 10.1016/j.mcna.2020.08.003 -
Seminars in Oncology Aug 2020Multiple large-scale, randomized controlled trials throughout the world have demonstrated screening mammography significantly reduces a woman's risk of dying from breast... (Review)
Review
Multiple large-scale, randomized controlled trials throughout the world have demonstrated screening mammography significantly reduces a woman's risk of dying from breast cancer. Despite the known mortality reduction, the perceived harms of mammography are weighed against the known value. Multiple national guidelines have moved away from recommending all women have annual screening mammograms beginning at age 40. Instead, many now encourage women at average risk for developing breast cancer to engage in shared decision-making with their providers, carefully weighing the perceived harms against the known benefits of mammography. These factors should be incorporated into the decision about when to begin and how often to screen. This paradigm shift has been particularly controversial as it relates to women in the 40-49-year age group, considering their incidence of breast cancer and therefore derived benefit of screening is lower, yet the breast cancers that do occur tend to be more aggressive and often require intensive therapy. Thus, debates ensue over the appropriate age at which to begin screening for breast cancer, how often screening should occur, and when to stop.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Early Detection of Cancer; Female; Humans; Mammography; Middle Aged
PubMed: 32513421
DOI: 10.1053/j.seminoncol.2020.05.002 -
Radiologic Clinics of North America Jan 2021Since its widespread introduction 30 years ago, screening mammography has contributed to substantial reduction in breast cancer-associated mortality, ranging from 15% to... (Review)
Review
Since its widespread introduction 30 years ago, screening mammography has contributed to substantial reduction in breast cancer-associated mortality, ranging from 15% to 50% in observational trials. It is currently the best examination available for the early diagnosis of breast cancer, when survival and treatment options are most favorable. However, like all medical tests and procedures, screening mammography has associated risks, including overdiagnosis and overtreatment, false-positive examinations, false-positive biopsies, and radiation exposure. Women should be aware of the benefits and risks of screening mammography in order to make the most appropriate care decisions for themselves.
Topics: Breast; Breast Neoplasms; Female; Humans; Mammography; Medical Overuse; Risk
PubMed: 33222997
DOI: 10.1016/j.rcl.2020.09.005 -
Radiologic Technology Nov 2019
Review
Topics: Breast Neoplasms; Female; Humans; Mammography; Safety Management
PubMed: 31685598
DOI: No ID Found